...
首页> 外文期刊>Drugs: education, prevention, and policy >Harm reduction knowledge and information exchange among secondary distributors in Sydney, Australia
【24h】

Harm reduction knowledge and information exchange among secondary distributors in Sydney, Australia

机译:澳大利亚悉尼的二级分销商之间减少危害的知识和信息交流

获取原文
获取原文并翻译 | 示例

摘要

Aims: Secondary syringe distribution involves the acquisition of injecting equipment by people who inject drugs (PWID) from authorized or 'safe' sources to be distributed to their peers. This article describes the characteristics of those who regularly engage in secondary distribution in Sydney, Australia, and their levels of knowledge about harm reduction. Methods: Data were collected through a cross-sectional study using surveys collected from PWID recruited from 35 pharmacies in metropolitan and regional Sydney. A two-page self-complete survey was distributed by pharmacy staff to each person buying or exchanging needles and syringes. Findings: Of the 602 participants in this study, 114 (18.9%) responded that they regularly engaged in secondary distribution. Despite no significant difference in knowledge about hepatitis C (HCV) transmission, secondary distributors were more likely than non-distributors to tell others specifically about how to get treatment for drug use (40.4% vs 30.2%, p = 0.04), and where to get sterile needles (64.0% vs 45.8%, p = 0.001), alcohol swabs or filters for injecting (41.2% vs 25.9%, p = 0.001). Conclusion: While overall secondary distributors were no more likely to pass on harm reduction information, secondary distributors were significantly more likely to tell others about some specific pieces of information, including where to get ancillary injecting equipment, where to get tested for HCV, and how to get treatment for drug use.
机译:目的:二手注射器的分销涉及从授权或“安全”来源注射毒品(PWID)的人获得的注射设备,并将其分发给同龄人。本文介绍了定期在澳大利亚悉尼进行二级分销的人的特征,以及他们对减少危害的知识水平。方法:通过横断面研究收集数据,该调查使用从大城市和悉尼地区的35家药房招募的PWID进行调查。药房工作人员向购买或交换针头和注射器的每个人分发了两页的自我完成调查。调查结果:在本研究的602名参与者中,有114名(18.9%)回答说,他们定期从事二级分销。尽管对丙型肝炎(HCV)传播的知识没有显着差异,但与非分销商相比,二级分销商更有可能向其他人具体告知如何获得药物使用治疗(40.4%vs 30.2%,p = 0.04),以及在何处取无菌针头(64.0%vs 45.8%,p = 0.001),酒精拭子或注射用过滤器(41.2%vs 25.9%,p = 0.001)。结论:虽然总体上二级分销商不太可能传递减低危害信息,但二级分销商更有可能告诉其他人一些特定的信息,包括从何处获得辅助注射设备,从何处进行HCV测试以及如何进行得到药物治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号